These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9193315)

  • 1. Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies.
    Backstrom JT; Hinkle RL; Flicker MR
    BMJ; 1997 Jun; 314(7095):1694-5. PubMed ID: 9193315
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.
    Blackwell N; Hayllar J; Kelly G
    BMJ; 1997 Jun; 314(7095):1694. PubMed ID: 9193313
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin.
    Mackenzie R; Klistorner A
    BMJ; 1998 Jan; 316(7126):233. PubMed ID: 9468717
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist.
    Harding GF
    BMJ; 1997 Jun; 314(7095):1694. PubMed ID: 9193314
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients.
    Harding GF
    BMJ; 1998 Jan; 316(7126):232-3. PubMed ID: 9468716
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent.
    Wong IC; Mawer GE; Sander JW
    BMJ; 1997 Jun; 314(7095):1693-4. PubMed ID: 9193312
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.
    Wilson EA; Brodie MJ
    BMJ; 1997 Jun; 314(7095):1693. PubMed ID: 9193311
    [No Abstract]   [Full Text] [Related]  

  • 8. Infantile spasms and vigabatrin. Visual field defects may be permanent.
    Lhatoo SD; Sander JW
    BMJ; 1999 Jan; 318(7175):57. PubMed ID: 10068225
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe persistent visual field constriction associated with vigabatrin.
    Eke T; Talbot JF; Lawden MC
    BMJ; 1997 Jan; 314(7075):180-1. PubMed ID: 9022432
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe constriction of the visual field associated with vigabatrin discovered by thorough examination of a 17-year old girl].
    Roubergue A; Pelosse B; Doummar D; Beauvais P; Montchilova M; Gonthier B; Billette de Villemeur T
    Arch Pediatr; 1999 Aug; 6(8):901-2. PubMed ID: 10472407
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
    Ruether K; Pung T; Kellner U; Schmitz B; Hartmann C; Seeliger M
    Arch Ophthalmol; 1998 Jun; 116(6):817-9. PubMed ID: 9639460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
    Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concentric changes in the visual field associated with GABA-mimetic antiepileptic agents].
    Nordmann JP; Baulac M; Van Egroo C
    J Fr Ophtalmol; 1999 May; 22(4):418-22. PubMed ID: 10365327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin-associated retinal cone system dysfunction.
    Roubertie A; Bellet H; Echenne B
    Neurology; 1998 Dec; 51(6):1779-81. PubMed ID: 9855564
    [No Abstract]   [Full Text] [Related]  

  • 17. Vigabatrin-associated retinal cone system dysfunction.
    Brigell MG
    Neurology; 1998 Dec; 51(6):1779-81. PubMed ID: 9855563
    [No Abstract]   [Full Text] [Related]  

  • 18. Vigabatrin-associated retinal cone system dysfunction.
    Beck RW
    Neurology; 1998 Dec; 51(6):1778-9; author reply 1779-81. PubMed ID: 9855562
    [No Abstract]   [Full Text] [Related]  

  • 19. [Constriction of the visual field by vigabatrin].
    Asensio Sánchez VM
    An Med Interna; 2002 Dec; 19(12):655-6. PubMed ID: 12593042
    [No Abstract]   [Full Text] [Related]  

  • 20. GABA and the ornithine delta-aminotransferase gene in vigabatrin-associated visual field defects.
    Hisama FM; Mattson RH; Lee HH; Felice K; Petroff OA
    Seizure; 2001 Oct; 10(7):505-7. PubMed ID: 11749107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.